Actylis – The Partner of Choice

Activities: Manufacturing Ingredients Research & Development

Trending Articles

  1. GSK completes acquisition of 35Pharma, gaining pulmonary hypertension candidate The company has completed its purchase of the Canada-based biopharma for $950m, handing it a drug that is a potentially “best-in-class” therapy for blood pressure diseases...
  2. Introducing DecFill XP: A New Era in Aseptic Filling By combining a breakthrough levitating transport system with next‑generation sustainable vials, DecFill XP establishes a new benchmark for compact, energy‑efficient, and...
  3. "Miracle" Alzheimer's drugs show no meaningful benefit, says major review Amyloid-clearing drugs hailed as a breakthrough for Alzheimer's treatment make "no meaningful difference to patients" and increase the risk of brain swelling and bleeding,...
  4. See. Try. Believe. Experience the Lyza 7000 FTIR with a 70-day risk free trial Laboratories can now evaluate the Lyza 7000 FTIR spectrometer in their own environment through a new 70-day, no-cost, no-risk trial program. The initiative allows teams to run...
  5. Aragen launches ChemiSHE, India's first women-led chemistry synthesis laboratory The firm has inaugurated ChemiSHE, a pioneering all-women chemistry synthesis laboratory at its Hyderabad campus, as part of a broader diversity initiative targeting the...

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

Related Content

Manufacturing

Actylis expands into VMS & Pharma with the acquisition of Pharm-Rx

The acquisition strengthens Actylis’ presence in the VMS and OTC markets
Manufacturing

Actylis appoints Scott Thomson as CEO

Scott will endeavour to globally expand the company's integrated manufacturing and sourcing strategy
Distribution

Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride

The two companies aim to expand the distribution of benzalkonium chloride within Europe
Manufacturing

Actylis adds a WFI production system in Canada

The manufacturer of raw materials has launched a Water for Injection (WFI) and additional ISO Class 7 manufacturing in Montreal, Canada
Manufacturing

Actylis opens 30,000 sqft cGMP API facility

The Eugene facility is the latest GMP manufacturing facility that Actylis has commissioned, along with the other GMP sites in Montreal, Limerick and Ahmedabad
Manufacturing

Actylis invests $450k in Manchester facility, UK

The modernisation work was completed during the summer of 2022
Manufacturing

The debut of Actylis signals the creation of a specialty ingredients manufacturing and sourcing powerhouse

The unique hybrid model provides unparalleled flexibility for individualised, customer-centric ingredient solutions along with exceptional supply chain dependability
Subscribe now